GCC Medical Devices Market: size, imports, registration and outlook 2026–2032

The GCC medical devices market — diagnostic imaging, patient monitoring, surgical instruments and implants, consumables, IVD instruments and hospital equipment — is small by global standards but high-value per bed and almost entirely imported. Published estimates for 2025 range from USD 8.4 bn to USD 13.0 bn; our central estimate is USD 10.5 bn, growing at about 6% to USD 15.8 bn by 2032. Saudi Arabia and the UAE together account for the large majority.

Demand follows bed-capacity expansion, replacement cycles at public hospitals, and the growth of private tertiary care. Supply is shaped by regulation (SFDA MDMA in Saudi Arabia; MOHAP federal registration in the UAE, with DoH and DHA facility-level requirements), by centralised public tendering (NUPCO; PureHealth’s Rafed), and by localisation incentives that favour manufacturers willing to assemble or manufacture in-region.

The chart shows the Consulting Wallah central estimate: published figures normalised to 2025, median taken, and projected at the median published growth rate. The published range for 2025 is USD 8.4 bn–USD 13.0 bn; differences are mostly scope.

Included: capital equipment (imaging, surgical, monitoring, dialysis, lab instruments), implants and interventional devices, single-use consumables, and IVD instruments and reagents where reported together. Excluded: pharmaceuticals; hospital IT; PPE commodity gloves/masks where reported separately. Regulators: SFDA (Saudi), MOHAP (UAE), MoPH (Qatar), MoH (Kuwait, Oman, Bahrain).

Shares as reported by the named sources; ranking is more reliable than the exact percentage.

• Saudi Arabia imports ~90% of medical devices; other GCC states ~85% (PharmaKnowl)
• Saudi Arabia accounts for 56-60% of GCC healthcare and device spending and 22.5% of the ME&A device market (PharmaKnowl; MedDeviceGuide)
• Hospitals accounted for 62.8% and Class II devices 65.2% of the Middle East device market (2023) (PharmaKnowl)
• ~400 GCC healthcare transactions 2021-Apr 2025, with Saudi and UAE ~92% of them (UAE 198, Saudi 170) (MedDeviceGuide)
• Saudi reprocessed devices market USD 7.8m (2024) to USD 21.1m (2030), 18.2% CAGR (Grand View via PharmaKnowl)
• Saudi cardiovascular devices USD 527m (2025) to USD 715m (2031); UAE cardiovascular devices USD 227m (2026) to USD 302m (2031), 5.87% CAGR (Mordor via PharmaKnowl)
• Dubai Healthcare City Phase 3 is an AED 8 bn (USD 2.18 bn) expansion; Dubai has 54 hospitals (MedDeviceGuide; Kinmed)
• NUPCO prequalification plus SFDA product registration are prerequisites to bid for Saudi public tenders (trade.gov)
• Frost & Sullivan expects GCC diagnostic and patient monitoring device market growth of 9-10%, aided by domestic MedTech manufacturing (AGBI)
• Kuwait Ministerial Decree 387/2025 created three IVD registration pathways (standards, fast-track, abridged) (PharmaKnowl)

Saudi Arabia

The largest device market in the region; SFDA registration via an authorised representative; NUPCO frameworks for public hospitals; localisation (Made in Saudi, NIDLP) and SPIMACO/NUPCO-linked JV programmes push assembly and manufacturing in-Kingdom.

UAE

Federal MOHAP registration; Abu Dhabi (DoH) and Dubai (DHA) add facility-level requirements; Rafed (PureHealth) and large private groups run central tenders; free zones (JAFZA, KIZAD, Dubai Science Park) host regional distribution and some assembly.

India link

India is a growing source of consumables, disposables, orthopaedic implants, dialysis consumables and lower-cost imaging for the GCC; Indian manufacturers with CE/ISO 13485 and SFDA/MOHAP registration win price-sensitive tenders. See UAE device registration.

Key companies named across the sources; local distributors and implementation partners matter as much as the brand in the GCC and India.

• Manufacturers and exporters: registration first, local partner second, tender readiness (catalogue data, GS1, structured quotation) third — see what GCC buyers need.
• Hospital leaders: equipment total cost of ownership (service contracts, consumables lock-in) outweighs purchase price; tender the bundle.
• Investors: local assembly/manufacturing JVs and regional distribution platforms are the policy-backed opportunity.

1. Towards Healthcare, GCC Medical Devices Market Size, Trends, Shares and Companies — towardshealthcare.com
2. PharmaKnowl, MedTech industry statistics in the Gulf markets (GCC) — pharmaknowl.com
3. MedDeviceGuide, MENA Medical Device Market 2026: Size, Investment, Growth Drivers — meddeviceguide.com
4. Meticulous Research, Middle East Medical Devices Market press release — meticulousresearch.com
5. Meticulous Research, Saudi Arabia Medical Devices Market press release — meticulousresearch.com
6. Shanghai Kinmed via EIN Presswire, MENA Medical Device Market to Hit $14.37 Billion by 2030, Kinmed Reports — norfolkdailynews.com
7. US ITA (trade.gov), Saudi Arabia Country Commercial Guide - Healthcare — trade.gov
8. AGBI, More GCC healthcare mergers likely as competition hots up — agbi.com
9. Towards Healthcare (GCC Medical Devices Market) (2026-05) — USD 8.44 bn (2025) to USD 16.19 bn (USD 9.01 bn in 2026) (2035), CAGR 6.73%; scope: GCC-wide, 12 product types; IVD dominant in 2025, diabetes care fastest-growing; hospitals & ASCs leading end user — source
10. Market Research Future (via PharmaKnowl) (2026) — USD 13 bn (2025) to USD 28.2 bn (2035), CAGR —; scope: GCC medical devices market — source
11. Consulting Wallah Network — anonymised observations from procurement and business-setup work with hospital groups and suppliers in the UAE, India and Bangladesh (2024–26), used for the GCC/India outlook and the “what it means” section.
12. Method. Each published figure is normalised to a 2025 base using its own CAGR; the Consulting Wallah central estimate is the median of the normalised figures (or the stated scope where noted) projected at the median CAGR to 2032. Country figures are quoted as published; where we add a CW estimate it is labelled.